Larimar Therapeutics, Inc.
USD3.30
-0.21 (-5.98%)
CEO
Carole S. Ben-Maimon
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.47
Prev. Close
$3.51
Day Low
$3.30
Day High
$3.48
52W Low
$2.22
52W High
$6.42
Market Cap
$0.28B
Volume
1.77M
| 55,150 |
| $3.33 |
| 20 May 2026 | Truitt Joseph | director | A-Award | Acquired | 55,150 | $3.33 |
| 20 May 2026 | THOMAS FRANK E | director | A-Award | Acquired | 55,150 | $3.33 |
| 20 May 2026 | Hamilton Thomas Edward | director | A-Award | Acquired | 55,150 | $3.33 |
| 20 May 2026 | LEFF JONATHAN S | director | A-Award | Acquired | 55,150 | $3.33 |
| 2 Mar 2026 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | P-Purchase | Acquired | 831,978 | $5.00 |
| 2 Mar 2026 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | P-Purchase | Acquired | 2,000,000 | $5.00 |
| 2 Mar 2026 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | P-Purchase | Acquired | 1,084,010 | $5.00 |
| 2 Mar 2026 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | P-Purchase | Acquired | 1,084,012 | $5.00 |